What are the possibilities for an adult patient with hypertension and an elevated aldosterone renin ratio (ARR) but a normal computed tomography (CT) adrenal scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Aldosterone-Renin Ratio with Normal CT Adrenal: Diagnostic Possibilities

The most likely diagnosis is bilateral idiopathic adrenal hyperplasia (IHA), which accounts for approximately 50-67% of primary aldosteronism cases and typically presents with normal or minimally abnormal adrenal imaging. 1, 2, 3

Understanding the Clinical Context

When you encounter an elevated aldosterone-renin ratio (ARR) but normal CT imaging, you are dealing with a common scenario in primary aldosteronism workup. The absence of a visible adenoma on CT does NOT exclude primary aldosteronism - in fact, the majority of cases will have normal-appearing adrenals on imaging. 2

Primary Diagnostic Possibilities

Bilateral Idiopathic Hyperplasia (Most Common)

  • This represents approximately 60-67% of all primary aldosteronism cases and is the most likely diagnosis when CT is normal 2, 3
  • The adrenal glands appear normal or show only minimal bilateral nodularity on CT imaging 2
  • These patients require lifelong medical therapy with mineralocorticoid receptor antagonists rather than surgery 3

Microscopic Aldosterone-Producing Adenoma

  • Small adenomas (<1 cm) may not be visible on standard CT imaging 2
  • These represent approximately one-third of primary aldosteronism cases but can be missed on imaging 2, 3
  • Adrenal venous sampling is essential to distinguish this from bilateral disease 2

Unilateral Adrenal Hyperplasia

  • Less common variant that appears normal on CT but shows unilateral aldosterone hypersecretion on adrenal venous sampling 3
  • Potentially curable with unilateral adrenalectomy 3

Critical Next Steps: Confirmatory Testing Required

You cannot proceed to subtype determination until autonomous aldosterone production is confirmed. 4, 1 The elevated ARR is only a screening test with low specificity due to common low-renin states from volume expansion or dietary salt. 4

Confirmatory Testing Options

Oral Sodium Loading Test (Preferred)

  • Administer high-sodium diet (>200 mEq/day) for 3 days with measurement of 24-hour urine aldosterone 1, 2
  • Failure to suppress urinary aldosterone below threshold confirms autonomous production 1
  • Ensure potassium repletion before testing, as hypokalemia suppresses aldosterone and causes false-negatives 1

Intravenous Saline Suppression Test

  • Infuse 2L normal saline over 4 hours 1
  • Plasma aldosterone >5-10 ng/dL after infusion confirms primary aldosteronism 1

Subtype Determination: The Critical Decision Point

Once primary aldosteronism is biochemically confirmed, adrenal venous sampling (AVS) is MANDATORY before considering surgery, even with normal CT imaging. 1, 5 This is the single most important step that determines whether the patient receives surgery (potentially curative) versus lifelong medical therapy.

Why Adrenal Venous Sampling is Essential

  • CT imaging alone is insufficient for treatment decisions - up to 25% of patients would undergo unnecessary adrenalectomy based on CT findings alone 1
  • Normal-appearing adrenals on CT can harbor microscopic adenomas or unilateral hyperplasia 2
  • Bilateral nodularity on CT may represent nonfunctioning incidentalomas with unilateral aldosterone production 2
  • AVS is the only test that definitively distinguishes unilateral from bilateral aldosterone hypersecretion 1, 2

Exception to AVS requirement: Patients <40 years old with clear unilateral adenoma on imaging, as bilateral hyperplasia is rare in this population 1

Important Medication Considerations

Several antihypertensive medications interfere with ARR interpretation and confirmatory testing:

  • Mineralocorticoid receptor antagonists (spironolactone, eplerenone) must be withdrawn for at least 4 weeks before any testing 4, 1
  • Beta-blockers and direct renin inhibitors suppress renin and cause false-positive ARR 4
  • ACE inhibitors and ARBs raise renin and can cause false-negative ARR, but paradoxically increase test sensitivity if renin remains suppressed despite these medications 4
  • Diuretics should be stopped when feasible 4

If medications cannot be safely discontinued, interpret results in the context of the specific drugs being taken. 1

Uncommon but Important Alternative Diagnosis

Primary Aldosteronism with Secondary Renal Damage

  • In patients with severe, longstanding hypertension, secondary kidney damage can cause renin to "escape" from suppression 6
  • These patients have elevated ARR due to disproportionately high aldosterone despite non-suppressed renin 6
  • They typically have elevated serum creatinine and may develop severe hyperkalemia when treated with spironolactone 6
  • This represents a medical emergency requiring early specific treatment to prevent further renal deterioration 6

Treatment Algorithm Based on Subtype

For Unilateral Disease (Adenoma or Unilateral Hyperplasia):

  • Laparoscopic unilateral adrenalectomy is the treatment of choice 1, 5, 7
  • Improves blood pressure in virtually 100% of patients 5, 7
  • Achieves complete cure of hypertension in approximately 50% of cases 5, 7
  • Earlier diagnosis and treatment improves cure rates by preventing irreversible vascular remodeling 5

For Bilateral Disease (Idiopathic Hyperplasia):

  • Lifelong medical therapy with mineralocorticoid receptor antagonists 5, 3
  • Spironolactone 25-50 mg daily is first-line treatment 1, 5
  • Eplerenone 50-100 mg daily is an alternative with fewer anti-androgenic side effects 5
  • Monitor potassium within 1 week of initiation and regularly thereafter, especially in patients with renal dysfunction or concurrent ACE inhibitor/ARB use 1

Common Pitfalls to Avoid

  • Never rely on presence or absence of hypokalemia - it is absent in approximately 50% of primary aldosteronism cases 1, 5, 7
  • Never proceed to surgery based on CT findings alone without adrenal venous sampling (except in young patients <40 with clear unilateral adenoma) 1
  • Never perform confirmatory testing while patient is on mineralocorticoid receptor antagonists - requires 4-week washout 1
  • Never assume normal CT excludes primary aldosteronism - bilateral hyperplasia and microscopic adenomas are common 2, 3

Clinical Significance and Urgency

Primary aldosteronism carries dramatically worse cardiovascular outcomes than essential hypertension at equivalent blood pressure levels, including 3.7-fold increase in heart failure, 4.2-fold increase in stroke, and 12.1-fold increase in atrial fibrillation. 7 This makes accurate diagnosis and appropriate treatment essential, not optional.

References

Guideline

Screening for Primary Aldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Primary aldosteronism: management issues.

Annals of the New York Academy of Sciences, 2002

Research

Primary aldosteronism: diagnostic and treatment strategies.

Nature clinical practice. Nephrology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management and Treatment of Primary Hyperaldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.

The Journal of clinical endocrinology and metabolism, 2000

Guideline

Aldosteronoma Clinical Features and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.